By leveraging 2D cell lines, mouse tumor cells, and PDO models, they conducted immunohistochemical analysis, showing that a PFKFB inhibitor combined with ER-targeted therapy effectively blocked tumor sphere formation in advanced BC models [17]. The gene discussed is ESR1; the disease is breast cancer.